Type A applications are still being accepted on a rolling basis.

P&F Type A:  $5,000 – $12,000 worth of core credits to provide equal access to services and expertise offered by any core. Rolling deadlines, abbreviated application forms, and streamlined review by Core Directors all contribute to a rapid and equitable distribution of core credits. Type A support is ideally suited for trainees who want to master a new expertise or acquire a new skill to enhance their competitiveness.  Applications for Type A projects will be accepted on a rolling basis and reviewed on an as needed basis.

Instructions Specific to P&F Type A:  New applications should be uploaded as a single PDF file (11-point Arial font size and 0.5” margins) that must include:

  • Page 1. Title, PI; Abstract (made public if awarded).
  • Page 2.  Description, Significance, Figures and Literature Cited,
  • Page 3.  Core use, Budget, and Justification, (signed by lab PI, if trainee/junior investigator), 1 page

NIH-style Biosketch for applicant only.

Type A projects do not require Institutional sign off by the applicant’s grant and contract office, unless required by the applicant institution’s policies.

Applicants must obtain signed approval for costs and feasibility from the directors of the cores they wish to access.

Project periods are limited to 12 months, and a progress report must be submitted within 120 days of the budget end date.

 

Please upload a single PDF of your application using the “Submit Application Here”, at the end of the Funding Opportunities section (below).

For questions about application submission and receipt, please contact Derek Stirewalt: dstirewa@fredhutch.org.

Application Process for Type A or Type B P&F Proposals

  1. Check guidelines for eligibility
    a. Priority will be given to Junior Investigators and Postdocs.
    b. Established Investigators starting a new line of Research in nonmalignant hematology – cannot be focused on currently funded project.
  2. Determine the type of grant you wish to apply for.a. Type A  – Core Usage Funds Only (C-UFO) up to $12,000 (no F&A, funds made available only at Core proposed).
    b. Type B – New Pilot Proposal (HCCC-P&F) up to $75,000 including recommended F&A (Use PHS 398 forms as detailed).
  3. Contact the core director(s) of the core you will be using to initiate guidance on feasibility and costs associated with core use.
  4. Write and submit proposals as a single PDF using the detailed guidelines on length and inclusions on the appropriate submission instruction page (Type A, Type B) prior to final due date and time.

No applications will be accepted after 5pm MST on the due date.

Additional Requirements

If an award is made, the submitted Abstract will be made public on the cceh.io website, along with the Project Title, PI Name(s), Institution, and award type.

Each publication, press release, or other document about research supported by an NIH award must include an acknowledgment of NIH award support and a disclaimer such as “Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number U24DK126127. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Awardees are also encouraged to refer to the “NIDDK Cooperative Centers of Excellence in Hematology Pilot &Feasibility Award” on their Biosketch and Other Support documents.

Awardees are expected to submit a final progress report within 120 days of the budget end date. The U24-funded HCCC may include this report, in part or in full, with its Annual Research Performance Progress Report (RPPR) to the NIH.

The HCCC may contact the PI of awards to review long-term outcomes. Awardees will be invited to present results at the annual NIDDK Hematology Centers Program Steering Committee meeting.

If not used in publications or grant submissions, data should be represented in Synapse or another relevant data repository as negative results.